LOGIN  |  REGISTER
Terns Pharmaceuticals

CareCloud to Announce Third Quarter 2023 Results on November 2, 2023

October 19, 2023 | Last Trade: US$3.55 0.37 11.48

SOMERSET, N.J., Oct. 19, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology solutions for medical practices and health systems nationwide, is set to unveil its financial results for the third quarter, concluding on September 30, 2023, before the market opens on Thursday, November 2, 2023. The company will be complementing this announcement with a conference call designed for investors, commencing at 8:30 a.m. Eastern Time.

To tune in to the live webcast of the conference call and access associated presentation slides, please visit ir.carecloud.com/events. For those who prefer an audio-only experience, an alternative option is available by dialing 631-891-4304 and mentioning "CareCloud Third Quarter 2023 Earnings Call." Listeners opting for audio-only will be required to download the corresponding slides, which can be found at ir.carecloud.com/events.

Following the conclusion of the call, a replay of the conference call along with the presentation slides will be accessible approximately one hour afterward, using the same link mentioned above. An audio-only option for the replay is also available by dialing 412-317-6671 and providing the access code 10022640.

About CareCloud

CareCloud (Nasdaq: CCLD, CCLDO, CCLDP) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, telehealth and patient experience management (PXM) at www.carecloud.com.

Follow CareCloud on LinkedInTwitter and Facebook.

For additional information, please visit our website at www.carecloud.com. To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com.

Company Contact:
Larry Steenvoorden
Chief Financial Officer
CareCloud, Inc.
This email address is being protected from spambots. You need JavaScript enabled to view it.

Investor Contact:
Asher Dewhurst
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.

Media Inquiries:
Alexis Feinberg
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.

Stock Quote

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page